Research Appraisalother

Vertically Oriented Assembly of a Few-Layer Ti3C2Tx Grid by Electric Field Inducing and Freeze Drying for Wearable Levodopa Sensing in Sweat

ACS sensorsWei, Na, Cheng, Junping, Wang, Xin et al.24 Apr 2026DOI

Clinical Snapshot

60CEBM
Evidence: Weakother

PICO Framework

P — PopulationParkinson's disease patients requiring levodopa monitoring
I — InterventionWearable electrochemical sensor using vertically assembled Ti3C2Tx grid with gold electrocatalyst
C — ComparatorConventional parallel assembly MXene electrodes and traditional levodopa monitoring methods
O — OutcomesDetection sensitivity (37 nM limit), linear detection ranges (1-30 μM and 30-160 μM), and feasibility of sweat-based levodopa monitoring

Bottom Line

This materials science study presents an innovative wearable sensor for detecting levodopa in sweat using vertically assembled MXene nanosheets. While the technical performance appears promising with nanomolar sensitivity, this remains a proof-of-concept study lacking clinical validation. The sensor achieved detection limits of 37 nM across two linear ranges, potentially enabling non-invasive monitoring of levodopa levels in Parkinson's patients. However, critical gaps include absence of correlation with plasma levels, interference studies with other sweat components, and long-term stability data. Before clinical implementation, rigorous validation studies comparing sweat-based measurements with established plasma monitoring methods are essential. The technology shows promise for personalised Parkinson's management but requires substantial further development and regulatory approval.

Evidence: Weak

Key Findings

  • P Value: Not reported

  • Effect Size: Detection limit of 37 nM with dual linear ranges of 1-30 μM and 30-160 μM

  • Primary Outcome: Successful development of vertically assembled Ti3C2Tx grid sensor for levodopa detection

  • Nnt Or Sensitivity: Detection sensitivity of 37 nM, specificity not quantified

  • Confidence Interval: Not reported

Clinical Application

Proof-of-concept demonstrated but requires extensive clinical validation before implementation Could complement TGA-approved levodopa formulations monitoring, potentially reducing need for frequent blood sampling in line with RACGP chronic disease management principles Parkinson's disease patients requiring therapeutic drug monitoring, particularly those with fluctuating motor symptoms

Abstract

Compared with the parallel assembly, the vertical assembly of MXene nanosheets on the substrate exhibits open three-dimensional porous structure, which is beneficial to the construction of high-performance electrodes. Herein, the vertically oriented assembly of Ti3C2Tx nanosheets is proposed by a novel preparation process of electric field inducing and freeze drying, resulting in the Ti3C2Tx grid with thin-wall and open porous structure. First, the electric field induces the formation of Ti3C2Tx hydrogel layer on the substrate. Second, freeze drying causes the growth of ice crystals for squeezing few-layer Ti3C2Tx nanosheets to stand up. More importantly, such a Ti3C2Tx grid with large surface area and intrinsic conductivity can effectively load electrocatalysts, resulting in the Au-Ti3C2Tx grid as a high-performance working electrode for the electrochemical detection of levodopa. The main parameters include 1-30 μM and 30-160 μM two-stage linear ranges and 37 nM detection limit. The structural advantages of Ti3C2Tx grid-based electrode materials are their three-dimensional conductive network and interconnected porous structure, which contribute to the penetration of the electrolyte, the diffusion of the analyte, and the electrocatalytic reaction. Furthermore, the self-adapting shape of the Ti3C2Tx grid leads to the fan-shaped Au-Ti3C2Tx grid collaborated with a self-designed leaf-like microfluidic. Ultimately, a wearable levodopa sensor composed of Au-Ti3C2Tx grid, microfluidic, flexible electronic system, and mobile phone client is established for detecting levodopa in human sweat, which is expected to help Parkinson's patients control the drug dosage. Our work proposes the vertically assembled Ti3C2Tx nanosheet loaded noble metal electrocatalysts to develop high-performance electrodes for electrochemical sensing.

Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service